EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis

Hedda Skogum Riise iD, Helene Thorvik iD, Lise Rystad Øie iD, Lars Jacob Stovner iD, Erling Andreas Tronvik iD, Mattias Linde iD, Knut Hagen, Samita Giri iD, Tore Wergeland iD

Cephalalgia · 2026-05 · 46 (5)

DOI: 10.1177/03331024261451481 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cephalalgia, online erschienen am 29.05.2026. Verfasst von Hedda Skogum Riise und 8 weiteren Autor:innen. Beteiligte Einrichtung: Norwegian Centre for Headache Research (NorHead), Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Hauptthemen laut MEDLINE: Migraine Disorders, Angiotensin Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of angiotensin II receptor blockers (ARBs) in migraine prophylaxis varies globally, partly due to insufficient evidence from randomized controlled trials (RCTs) supporting their efficacy. We aimed to conduct a systematic review and meta-analysis of ARBs in migraine prophylaxis.

Methods

We searched PubMed/MEDLINE, Embase, Cochrane, Google Scholar, Clinicaltrials.gov, ITCRP, and EudraCT from database inception to 22 September 2025. The searches were conducted between 19 and 22 September 2025 for controlled trials comparing any ARB to placebo or other preventive migraine drugs in individuals with episodic or chronic migraine. Guidelines, letters, editorials, narrative reviews, case reports, and news were excluded. Summary data were extracted by two reviewers, and random-effects meta-analyses were performed, with heterogeneity assessed using Cochrane I 2 statistic. Primary outcomes were monthly headache/migraine days or attacks, and response rates. Adverse event occurrence was also assessed. The risk of bias was assessed using the Cochrane RoB2 tool and the certainty of evidence was assessed using GRADEpro. The study was pre-registered in Prospero (CRD42023405372) and received no funding.

Results

Four trials published between 2003 and 2025 were included in the meta-analysis: three RCTs on candesartan, and one on telmisartan. All four studies reported the outcomes migraine days and responder (≥50% reduction of migraine days) rates, and three reported headache days. A total of 659 participants were included in the meta-analysis. The combined effect size for migraine days and headache days were reductions of −1.00 (95% CI: −1.51 to −0.49, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersAngiotensin Receptor AntagonistsHumansRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

angiotensin II receptor blockerscandesartanmigraine prophylaxistelmisartan

Substanzen

Angiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Norwegian Centre for Headache Research (NorHead), Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
  • Department of Neuromedicine and Movement Sciences, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Regional Migraine Unit, Sahlgrenska University Hospital, Gothenburg, Sweden.

ORCID-Profile: Hedda Skogum Riise, Helene Thorvik, Lise Rystad Øie, Lars Jacob Stovner, Erling Andreas Tronvik, Mattias Linde, Samita Giri, Tore Wergeland

Zitieren

APA

Riise, H. S., Thorvik, H., Øie, L. R., Stovner, L. J., Tronvik, E. A., Linde, M., Hagen, K., Giri, S., & Wergeland, T. (2026). The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis. Cephalalgia, 46(5). https://doi.org/10.1177/03331024261451481

Vancouver

Riise HS, Thorvik H, Øie LR, Stovner LJ, Tronvik EA, Linde M, et al. The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis. Cephalalgia. 2026;46(5). doi:10.1177/03331024261451481

BibTeX
@article{Riise2026,
  author = {Riise, Hedda Skogum and Thorvik, Helene and Øie, Lise Rystad and Stovner, Lars Jacob and Tronvik, Erling Andreas and Linde, Mattias and Hagen, Knut and Giri, Samita and Wergeland, Tore},
  title = {The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis},
  journal = {Cephalalgia},
  year = {2026},
  volume = {46},
  number = {5},
  doi = {10.1177/03331024261451481}
}
Kostenlos starten →